An interventional study of Domiciliary VR-based motor rehabilitation and Domiciliary occupational therapy for motor rehabilitation in Hemiparesis, Functional Independence and Movement Disorder, sponsored by Universitat Pompeu Fabra. Completed. Open to participants aged 45 Years to 85 Years. Per ClinicalTrials.gov, last updated 2016-03-04.
Sponsored by Universitat Pompeu Fabra · Not applicable, Interventional, and Treatment
The purpose of this study is to determine whether domiciliary VR-based telerehabilitation is superior than domiciliary occupational therapy for inducing functional gains, enhancing corticospinal excitability, and cortical reorganization.
320 studies on the registry are indexed under Movement Disorders; 98 are open to participants now.
This study's enrollment of 39 is below the median of 46 across 180 interventional studies indexed under Movement Disorders.
Browse Movement Disorders studies →Universitat Pompeu Fabra is the lead sponsor of 12 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
3 weeks of home-based treatment for motor training using a virtual reality rehabilitation setup.
Behavioral: Domiciliary VR-based motor rehabilitation
3 weeks of home-based occupational therapy for motor training.
Behavioral: Domiciliary occupational therapy for motor rehabilitation
3 weeks, 1 to 3 sessions a day, 20min per sessions, of physical therapy using a VR gaming system.
3 weeks, 1 to 3 sessions a day, 20min per sessions, of physical therapy using a VR gaming system.
Change in motor function for activities of daily living as measured by Chedoke Arm Hand Inventory clinical
Time frame: At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.
Change in depression as measured by the Hamilton scale
Time frame: At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.
Change in motor function as measured by the Medical Research Council scale
Time frame: At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.
Change in spasticity for the upper arms as measured by the Ashworth scale
Time frame: At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.
Change in cognitive function as measured by the Mini-mental State Evaluation test
Time frame: At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.
Change in Grip Force as measured by a grip dynamometer
Time frame: At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.
Change in shoulder pain as measured by the Visual Analog Assessment scale
Time frame: At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.
Change in motor function as measured by the upper extremity Fugl-Meyer Assessment
Time frame: At baseline, at 3-weeks (after intervention), and at 12-weeks follow-up.
No study locations are listed for this record.
This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universitat Pompeu Fabra